BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 6593983)

  • 1. Transphenoidal removal of GH secreting adenomas: method of choice for the treatment of acromegaly.
    Tolis G; Saltiel P; Koutsilieris M; Bertrand G
    Acta Endocrinol Suppl (Copenh); 1984; 265():34-5. PubMed ID: 6593983
    [No Abstract]   [Full Text] [Related]  

  • 2. Results of the lateral rhinotomy approach in transsphenoidal microsurgery for growth hormone-secreting pituitary adenoma.
    Jakobsson KE; Petruson B; Elfverson J; Bengtsson BA
    Br J Neurosurg; 1995; 9(6):763-8. PubMed ID: 8719832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Results of transsphenoidal surgery for growth-hormone secreting pituitary adenomas.
    Saitoh Y; Mori S; Arita N; Hayakawa T; Mogami H; Ohta M; Uozumi T
    Neurol Med Chir (Tokyo); 1984 Jul; 24(7):478-84. PubMed ID: 6208498
    [No Abstract]   [Full Text] [Related]  

  • 4. Transphenoidal microsurgery for acromegaly. Successful treatment with preservation of pituitary function.
    Becker DP; Atkinson R; Sakalas R; Vries JK; Young HF; Vines FS; Martinez J
    Confin Neurol; 1974; 36(2):101-5. PubMed ID: 4824576
    [No Abstract]   [Full Text] [Related]  

  • 5. Special problems with neurosurgical treatments of hormone-secreting pituitary adenomas in children.
    Lüdecke DK; Herrmann HD; Schulte FJ
    Prog Exp Tumor Res; 1987; 30():362-70. PubMed ID: 3628819
    [No Abstract]   [Full Text] [Related]  

  • 6. Intraoperative Scoring System to Predict Postoperative Remission in Endoscopic Endonasal Transsphenoidal Surgery for Growth Hormone-Secreting Pituitary Adenomas.
    Yano S; Shinojima N; Kawashima J; Kondo T; Hide T
    World Neurosurg; 2017 Sep; 105():375-385. PubMed ID: 28602880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Transsphenoidal selective removal of the functioning pituitary microadenomas--operative results (author's transl)].
    Misumi S; Shimizu T; Shibasaki T; Onoda K; Fujii T; Takeda F
    Neurol Med Chir (Tokyo); 1979 Aug; 19(8):817-26. PubMed ID: 91136
    [No Abstract]   [Full Text] [Related]  

  • 8. [Growth pituitary adenomas: evaluation of 20 patients].
    Tella OI; Herculano MA; Delcello R; Aguiar PH
    Arq Neuropsiquiatr; 2002 Mar; 60(1):123-8. PubMed ID: 11965421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative short-term administration of octreotide for facilitating transsphenoidal removal of invasive growth hormone-secreting macroadenomas.
    Tachibana E; Saito K; Yoshida J
    Neurol Med Chir (Tokyo); 1999 Jul; 39(7):496-9; discussion 499-501. PubMed ID: 10437377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The acromegaly--gigantism syndrome. Report of four cases treated surgically.
    Zampieri P; Scanarini M; Sicolo N; Andrioli G; Mingrino S
    Surg Neurol; 1983 Dec; 20(6):498-503. PubMed ID: 6648790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Desensitization to somatostatin analogue (Octreotide) observed in a patient with acromegaly.
    Haraguchi K; Ohtaka M; Takazawa K; Endo T; Onaya T
    Endocr J; 1995 Apr; 42(2):295-300. PubMed ID: 7627275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transsphenoidal microsurgery for selective removal of functional pituitary microadenomas.
    Nielson KD; Watts C; Clark K
    World J Surg; 1977 Jan; 1(1):79-84. PubMed ID: 194423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alteration of the collagen type III/type I ratio and intracranial saccular aneurysms in GH-secreting hypophyseal adenomas.
    Acqui M; Ferrante L; Matronardi L; d'Addetta R
    Ital J Neurol Sci; 1988 Aug; 9(4):365-8. PubMed ID: 3220712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgical management of GH-secreting pituitary adenomas: an outcome study using modern remission criteria.
    Kreutzer J; Vance ML; Lopes MB; Laws ER
    J Clin Endocrinol Metab; 2001 Sep; 86(9):4072-7. PubMed ID: 11549628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Results of transphenoidal surgery and radiotherapy in the treatment of acromegaly].
    López JM; Méndez J; Mahana D; Vega J; Rodríguez JA; Michaud P; Arteaga E
    Rev Med Chil; 1985 Jan; 113(1):27-31. PubMed ID: 4081381
    [No Abstract]   [Full Text] [Related]  

  • 16. Transphenoidal surgery in acromegalic patients: anatomical considerations and potential pitfalls.
    Carrabba G; Locatelli M; Mattei L; Guastella C; Mantovani G; Rampini P; Gaini SM
    Acta Neurochir (Wien); 2013 Jan; 155(1):125-30; discussion 130. PubMed ID: 23180167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acromegaly: selection parameters and operative results.
    Weiss MH
    Clin Neurosurg; 1980; 27():31-7. PubMed ID: 7273559
    [No Abstract]   [Full Text] [Related]  

  • 18. Percent reduction of growth hormone levels correlates closely with percent resected tumor volume in acromegaly.
    Schwyzer L; Starke RM; Jane JA; Oldfield EH
    J Neurosurg; 2015 Apr; 122(4):798-802. PubMed ID: 25423276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transsphenoidal surgery for growth hormone-secreting pituitary adenomas in 130 patients.
    Shirvani M; Motiei-Langroudi R
    World Neurosurg; 2014 Jan; 81(1):125-30. PubMed ID: 23313263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acromegaly in a patient with normal pituitary gland and somatotropic adenoma located in the sphenoid sinus.
    Kurowska M; Tarach JS; Zgliczyński W; Malicka J; Zieliński G; Janczarek M
    Endokrynol Pol; 2008; 59(4):348-51. PubMed ID: 18777506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.